Chronic Lower Back Pain Market Report 2026

Chronic Lower Back Pain Market Overview

• Chronic Lower Back Pain market size has reached to $8.04 billion in 2025 • Expected to grow to $10.06 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Rising Geriatric Demographics Fuel Expansion In Chronic Lower Back Pain Market • Market Trend: Revolutionizing Chronic Back Pain Treatment With Abbott's Breakthrough In Spinal Cord Stimulation Technology • North America was the largest region in 2025.

The key promising market opportunities in the chronic lower back pain market include: • Imaging Guidelines (Segmentation By Diagnosis) → Expected gain of $946.21 Million • Hospitals (Segmentation By End-User) → Expected gain of $818.6 Million • Diskogenic Pain (Segmentation By Type Of Pain) → Expected gain of $701.24 Million

What Is Covered Under Chronic Lower Back Pain Market?

Chronic low back pain (CLBP) refers to a pain that persists for 12 weeks or more despite the treatment of the underlying cause of acute low back pain or the initial injury. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression, and/or anxiety. The main types of chronic lower back pain are discogenic pain, lumbar spinal stenosis, sacroiliac pain, facet-joint pain, radicular pain, muscular pain, and others. Discogenic pain refers to a form of low back pain that results from a damaged spinal disc, especially from degenerative disc disease, which happens naturally with aging. It is diagnosed with a clinical history, physical examination, imaging guidelines, and assessment of pain, and treated in various healthcare facilities such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

What Is The Chronic Lower Back Pain Market Growth Forecast?

The chronic lower back pain market size is expected to see steady growth in the next few years. It will grow to $10.06 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing demand for non-invasive therapies, growing adoption of digital therapeutics, expansion of outpatient pain management services, rising focus on personalized medicine, increased investments in chronic pain research. Major trends in the forecast period include increasing adoption of multimodal pain management approaches, rising use of minimally invasive interventions, growing integration of digital pain monitoring tools, expansion of personalized treatment pathways, enhanced focus on non-opioid therapies.

What Is The Driver Of The Chronic Lower Back Pain Market?

A growth in the geriatric population is expected to boost the growth of the chronic lower back pain market going forward. Geriatric population refer to a population of older people with 65 years and above. In the geriatric population, age-related neurodegenerative and musculoskeletal conditions such as arthritis and osteoarthritis progress rapidly, causing weakness and painful complaints that lead to chronic back pain and reduced physical activities. For instance, in May 2024, according to the Administration for Community Living, a US-based government agency, in 2022, 17.3% of the population was 65 or older. This percentage is expected to increase to 22% by 2040. Therefore, the growth in the geriatric population is driving the growth of the chronic lower back pain industry.

How Will The Drivers Impact Growth In The Global Chronic Lower Back Pain Market?

• Increasing Healthcare Expenditure (Medium) – The increasing healthcare expenditure will become a key driver of growth in the chronic lower back pain market by 2030. As governments and private sectors allocate more resources towards healthcare, there is a greater capacity for investment in advanced diagnostics, treatments and patient care for chronic conditions, including lower back pain. This increase in spending facilitates better access to healthcare services, enabling early diagnosis and more effective management of chronic lower back pain. As a result, the increasing healthcare expenditure is anticipated to contributing to annual growth in the market. • Rising Aging Population (Low) – The rising aging population will emerge as a major factor driving the expansion of the market by 2030. As people age, they are more likely to experience degenerative changes in their spine, such as osteoarthritis, disc degeneration and reduced bone density, all of which contribute to chronic lower back pain. As a result, the rising aging population is anticipated to contributing to annual growth in the market. • Rising Prevalence of Chronic Diseases (Low) – The rising prevalence of chronic diseases will serve as a key growth catalyst for the market by 2030. Diseases such as obesity, diabetes, arthritis and osteoporosis can contribute to or worsen lower back pain through mechanisms like increased mechanical stress on the spine, systemic inflammation and reduced bone density. As a result, the rising prevalence of chronic diseases is anticipated to contributing to annual growth in the market. • Increasing Healthcare Access In Emerging Markets (Low) – The increasing healthcare access in emerging markets will become a significant driver contributing to the growth of the market by 2030. As healthcare infrastructure expands and becomes more accessible in these regions, more individuals with chronic lower back pain can seek diagnosis and treatment. Enhanced access to healthcare means that people are more likely to receive early intervention, which is crucial in managing and mitigating the progression of chronic conditions. As a result, the increasing healthcare access is anticipated to contributing to annual growth in the market.

How Will The Restraints Impact Growth In The Global Chronic Lower Back Pain Market?

• Economic Downturns (Medium) – Economic Downturns will restrict the growth of the Chronic Lower Back Pain market during the forecast period. Economic downturns reduce healthcare spending as patients defer treatment and employers cut healthcare benefits. Reduced disposable income may lead to delayed diagnosis and treatment for chronic back pain conditions. Economic uncertainty can also impact investment in pain management research and development, limiting innovation and market growth.

Key Players In The Global Chronic Lower Back Pain Market

Major companies operating in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy's Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Global Chronic Lower Back Pain Market Trends and Insights

Major companies operating in the chronic lower back pain market are developing products with advanced technologies such as BurstDR SCS technology to offer new options for patients. BurstDR SCS technology is a proprietary spinal cord stimulation (SCS) therapy that works by using mild electrical pulses to change pain signals as they travel from the spinal cord to the brain. For instance, in May 2023, Abbott Laboratories, a US-based medical device company received FDA approval for its Spinal Cord Stimulation (SCS) devices including the Proclaim SCS Family and Eterna SCS System for the treatment of chronic back pain. Abbott's SCS devices deliver its proprietary BurstDR stimulation waveform, a superior therapy designed to more closely mimic how pain signals travel to the brain and treat the emotional suffering related to pain, unlike traditional tonic stimulation.

What Are Latest Mergers And Acquisitions In The Chronic Lower Back Pain Market?

In November 2023, Boston Scientific, a US-based biotechnology engineering firm, acquired Relievant Medsystems, Inc. for $850 million. This acquisition enhances Boston Scientific's portfolio in chronic pain management by incorporating Relievant's intracept intraosseous nerve ablation system, which is specifically designed to treat vertebrogenic pain, a type of chronic lower back pain. Relievant Medsystems Inc. is a US-based medical equipment manufacturing company.

What Defines the Chronic Lower Back Pain Market?

The chronic low back pain market includes revenues earned by entities by providing low back pain treatment services such as pain management services, and neuropathic and nociceptive pain management. Establishments that provide long treatment plans and management services are included in this market. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Lower Back Pain Market Report 2026?

The chronic lower back pain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic lower back pain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.